Table 2.

Scoring System for DIC Established by the JMHW.^{56 a}

Score
Criteria			Points
1. Underlying disease		(+)	1
		(−)	0
2. Symptoms	(1) Bleeding tendency	(+)	1
		(−)	0
	(2) Symptom caused by organ dysfunction	(+)	1
		(−)	0
3. Laboratory data	(1) Plasma FDP (µg/mL)	≥40	3
		20-40	2
		10-20	1
		<10	0
	(2) Platelet count (× 109/L)	≤50	3
		50-80	2
		80-120	1
		>120	0
	(3) Plasma fibrinogen (mg/dL)	≤100	2
		100-150	1
		>150	0
	(4) Prothrombin time ratio (PT of patient/PT of control)	≥1.67	2
		1.25-1.67	1
		<1.25	0
Supplemental Data
(1) Detection of soluble fibrin monomer
(2) Increase in d-dimers
(3) Increase in thrombin–antithrombin complex
(4) Increase plasmin–antiplasmin complex
(5) Exacerbation of FDP, platelet, fibrinogen within several days
(6) Improvement of data with anticoagulant therapy
Interpretation
1. Definite DIC	(1) Patients who do not have leukemia, pernicious anemia, liver cirrhosis, or who are not under cancer chemotherapy	More than 7 or 6 points with more than 2 of supplemental data
	(2) Patients who have leukemia, pernicious anemia, or who are under cancer chemotherapy points for bleeding tendency and platelet are not included	More than 4 or 3 points with more than 2 of supplemental data
	(3) Patients who have liver cirrhosis	More than 10 or 9 points with more than 2 of supplemental data
2. Probable DIC	(1) Patients who do not have leukemia, pernicious anemia, liver cirrhosis, or who are not under cancer chemotherapy	6 points
	(2) Patients who have leukemia, pernicious anemia, or who are under cancer chemotherapy points for bleeding tendency and platelet are not included	3 points
	(3) Patients who have liver cirrhosis	9 points